Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 7/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.43 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | RARA | P10276 | 1/20 | 0.41 |
| ▸ | RARB | P10826 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12355689 | 0.86 | RARA (0.53) | MAOBMAPTCRBNMAOARARA | |
| SCHEMBL2330395 | 0.85 | RARA (0.52) | MAOBKCNH2MAOARARARARB | |
| SCHEMBL4838140 | 0.83 | MAPT (0.46) | MAOBMAPTCRBNMAOA | |
| SCHEMBL25934294 | 0.83 | CRBN (0.47) | MAOBMAPTCRBNMAOARARA | |
| SCHEMBL15809020 | 0.83 | MAOB (0.47) | MAOBKCNH2CACNA1BMAPT | |
| SCHEMBL14261935 | 0.82 | MAOA (0.58) | MAOBCRBNMAOARARARARB | |
| SCHEMBL25313819 | 0.82 | MAPT (0.45) | MAOBMAPTCRBNMAOA | |
| Hydrochloric Acid SCHEMBL4838135 | 0.82 | PARP10 (0.45) | MAOBMAPTCRBNMAOA | |
| SCHEMBL2334552 | 0.80 | MAOB (0.42) | MAOBKCNH2CACNA1BMAPT | |
| SCHEMBL21202180 | 0.80 | KDM4E (0.50) | MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107011924-B | Photoalignment materials with side substitution | 罗利克有限公司 | 2021-06-01 | — | — | CN | disclosed |
| EP-2534191-B1 | PHOTOALIGNING MATERIAL WITH LATERAL SUBSTITUTION | ROLIC TECH AG (CH) | 2020-04-15 | — | — | EP | disclosed |
| EP-2534191-A1 | PHOTOALIGNING MATERIAL WITH LATERAL SUBSTITUTION | Rolic AG (CH) | 2012-12-19 | — | — | EP | disclosed |
| US-20120316317-A1 | PHOTOALIGNING MATERIAL WITH LATERAL SUBSTITUTION | ROLIC AG (CH) | 2012-12-13 | — | — | US | disclosed |
| WO-2011098461-A1 | PHOTOALIGNING MATERIAL WITH LATERAL SUBSTITUTION | ROLIC AG (CH) | 2011-08-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120316317-A1 | PHOTOALIGNING MATERIAL WITH LATERAL SUBSTITUTION | LATS1, LATS2, LCP1 | MAOB 4449/4885KCNH2 2836/4885CACNA1B 948/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.